Clinical Trial Update: Defibrotide in Children With High Risk Kawasaki Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating defibrotide in children at high risk with Kawasaki disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kawasaki Disease

Drugs mentioned

• Defibrotide (defibrotide)

Snippet

Sponsor: New York Medical College | Conditions: Kawasaki Disease | Phase 2 | Status: UNKNOWN